Carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion. Reversal by concomitant phenytoin therapy.
The syndrome of inappropriate antidiuretic hormone secretion, with marked hyponatremia, was observed in an elderly women who was taking carbamazepine for trigeminal neuralgia. Subsequent studies revealed this effect to be directly related to the administration of the drug. Substantial water retention has not been previously described in patients taking normal volumes of fluid and taking standard doses of carbamazepine. Additionally, it was determined that the antidiuretic effect of carbamazepine could be blocked by phenytoin. The actions of both drugs on renal water excretion, and the interactions of the drugs were observed to be dose-related.
D000368:Aged; D002220:Carbamazepine / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced* / Q000188:drug therapy; D010672:Phenytoin / Q000627:therapeutic use*; D013577:Syndrome; D014277:Trigeminal Neuralgia / Q000188:drug therapy; D014667:Vasopressins / Q000378:metabolism*
D014667:Vasopressins; D002220:Carbamazepine; D010672:Phenytoin